Do close-up vaccines bounce back? 6 years of clinical data give the answer

In recent years, medical health information has continued to receive public attention, and the service capabilities of the industry have been improving. Recently, there have been several scandals on the Internet about nearsighted surgery treatment that have spread widely. Do you believe that eye doctors themselves do not do nearsighted surgery, after a few years they will bounce back, or better yet not do it.

The answers to these questions can be found in the findings of a conference at the 2026 Hong Kong Ophthalmic Forum, a national conference on the innovation of eyeglasses and clinical practice empowerment at the Summit Forum. But if you seriously ask an ophthalmologist, they will answer you very differently. In this forum, it was DragonList® PR artificial crystals with crystalline eyelids that were independently developed by Ebonode in the country.

Before we can understand what the surgery itself is, we need to be clear: what we are discussing today is crystalline eyelid artificial crystalline implantation therapy (PIOL surgery), commonly known as eye lens implantation, which is a method of implanting microscopic artificial crystals into the eye, rather than cutting corners of the lens. Understanding this premise and seeing the rumors, there will be a new understanding. The main difference between the two is: laser surgery is a permanent corneal shape-shifting treatment, a type of acupuncture reduction surgical treatment; whereas eyeglasses, in the case of immobile cornea, place a thin artificial crystal into the eye to complete a refractive lens, which is theoretically reversible, and restore the original shape of the eye after removal.

Some ophthalmologists, because their work requires frequent use of microscopes, long-term precision operations, special needs for post-operative retinal detachment, will choose a more conservative approach, or temporarily no surgical treatment. In other words, the safety and effectiveness of the initial treatment itself is verifiable, and the individual choice of doctors does not represent the industry's overall judgment on the path of this technology. Behind this is a key medical logic: surgery is a means of blurring vision, not a root remedy for nearsightedness.

As for the celebrity in the business who wears the glasses, whether his eye conditions are suitable for surgery, whether he is willing to have surgery, we don't know for sure, but it does indicate one thing: not the surgery is bad, but the surgery is not suitable for everyone. After surgery, if the eyes are not taken care of, there may still be visual fluctuations or eye-related complications. Professor Chen Liang, of the University of Xiamen's affiliated Xiamen Ophthalmology Center, shared a point of view on clinical practice communication at the conference: some patients do not undergo surgery because, after a professional evaluation, it was found that their eye conditions determine the risk of some type of surgical treatment.

In clinical practice, it is not a failure of surgery, but a success of standardized assessment. The question is whether there are direct long-term data that can be answered. Professor Roya, a Beijing-based medical association of the Chinese Academy of Medical Sciences and Institute of Medicine, announced at the meeting the results of a 6-year follow-up of a clinical trial of the non-globular crystalline artificial crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystall At the same time, the relevant departments are also continuing to promote the regulation and health development of the industry.

Prof. Liang Gang, an affiliated medical institution of Yunnan University, also reported at the conference comparative research data: compared to the pre-operative, the Longxin® PR implantation back-ball gap significantly decreased, the upper-stage gap and the trifoliate did not increase significantly, while the upper-stage gap and the trifoliate in the ICL group showed a significant increase in follow-up. This is not propaganda, but follow-up data from clinical practice registration studies.

This means that long-term maintenance of the optical quality of the long-term, there are certain structural design advantages. Patient feedback, left eye, long-term vision quality is better than the right eye during the day and at night. The first example: patients with thin cornea, high near-sightedness associated with visual impairment, who had previously chosen to have limited vision, who had a positive visual acuity of 0.

5 a day after implantation of Longxin® PR, demonstrated the ability of the crystal to adapt to highly near-sighted patients. The second example: patients with visual impairment with blurred vision, right eye 0. 3, left eye 1.

0, right eye vision improved to 0. 8 a week after surgery, left eye maintained 1. 2, eyelid depth and angle of vision were good, and the angle of inclination was stable.

Prof. Chen Zheng discussed this cognitive bias, which is the most common in clinical practice communication. To answer this question, it is necessary to clarify that there is a clear racial difference in the anatomical parameters of the cataract.

It is in this context that the Longxin® PR is the second globally developed and the first self-developed crystalline artificial crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline crystalline cry Degree-to-degree particle density of 0. 25D, which is more subtle in the accuracy of the measurement matches, is particularly applicable to patients who are sensitive to measurements. It is noteworthy that this trend also reflects to some extent the shift in the concept of industry services.

In this forum, Prof. Roya, a Beijing-based association of medical institutions of the Chinese Academy of Medical Sciences, shared the results of the six-year follow-up of Longxin®PR and ICL's Phase III Clinical Practice Control Study: the ratio of the longxin®PR group's post-group-equivalent spherical mirrors at ±0. 5D was 93%, the ICL group was 80%; the two groups of efficacy and safety indices were equivalent, while Longxin®PR's performance in linear stability was more prominent.

Seven, the surgical treatment technology is mature, but you still need to know that this statistic says one thing must be clear: the advances in surgical treatment technology cannot replace the individual evaluation of each patient. Head-to-head data, referred to as ICL, is the most direct basis for breaking down the inherent cognitive bias of low-end acupuncture. Prof.

Wang Xiaojin, of the University of Zhejiang, an affiliated institution of ophthalmology, noted at the meeting that the increase in the hardness of the material of Longxin®PR has brought better stability, but also raised higher demands on the operation of the surgical treatment. Professor Shenzhen, the first medical institution affiliated with Zhejiang University School of Medicine, also emphasized in his concluding speech that long-term safety data needs to be continuously accumulated, and that a complete chain of evidence needs to be provided from the testing of Zhejiang innovation to the application of Zhejiang clinical practice. However, the following points should be understood by every friend considering surgical treatment: 1.

There is no one surgical treatment for everyone. 3. Pre-surgical assessment is a safe starting point.

Highly close-sighted eye changes still exist after surgery, and regular checkups are still needed. 4. The doctor's recommendation is that all information be given priority.

Pre-surgical checkups are the necessary process for your doctor to screen for the right regimen, rather than go through the procedure. Q&A: Crystalline implant initiation therapy, the five things you most want to know Q1: Will your vision decrease after the initial regimen? For example, in Phase III clinical practice trials, 6 years of follow-up data showed that 93% of patients with globular equivalence gauges maintained within ±0.

5D, and long-term refractive stability is supported by clinical practice data. The lens itself is a stable optical component, and the refractive gauge after implantation is usually stable. Regular inspection is a necessary component of long-term vision health.

However, it should be noted that vision may still be affected if excessive eye use causes nearsightedness to deepen after surgery, or if there is a highly nearsighted under-eye progression. The lower limit for adaptation to the depth of the anterior chamber of the lens is relatively wide (e. g.

≥2. 5 mm), but whether the surgical treatment can be evaluated as a surgical treatment must ultimately be determined by a doctor who combines multiple inspections and inspections to make a comprehensive judgment, not based on a single indicator. There are certain requirements for the depth of the anterior chamber of the lens and the conditions for adaptation of different products.

The size of the pupils and the size of the crystalline optical area are closely related. Q3: Will the surgery of the lens have night vision problems such as fluorescence, fluorescence? Large optical area crystals (such as Large Optical Area 6.

0) are more extensively scattered in night pupils and can theoretically reduce the fluorescence problems caused by the optical area not covering the pupils. Q4: Can this type of treatment be removed, but individual differences exist, and the size of the pre-operative dark pupil is one of the key parameters for evaluation. A feature of the internal lens is that theoretically irreversible crystals can be removed and the eyes can be restored to pre-operative condition after removal.

However, this does not mean that removing surgery at will is the same as surgery in the eye, and there are certain risks. For patients with combined scattering, there are currently several treatment options: using scattering positive crystals (Toric crystals), using corneal loosening cuts, or instantaneous laser-assisted corneal cuts, etc. Q5: Can scattering be treated simultaneously with ophthalmic surgery?

Prof. Carey, of the Institute of Ophthalmology in Wuhan, said that the FPS laser-assisted corneal incision has a 100% accuracy of residual scattering within ±0. 50D when scattered below 200 degrees Celsius.

This article is for reference only to healthcare professionals and readers who want to know about the relevant medical information, and does not represent the therapeutic commitment of any product. For information on surgical treatment adaptation certificates and personalized programs, please consult with a regular medical institution and follow medical professional advice. The information contained herein is not intended for any product procurement, promotion of any product, or application beyond the approved scope of any product.

The International Health Service System of China is constantly monitoring the latest developments in the field of medical health to provide you with authority, reliable information and medical services. If you need further advice on this, please contact authorized experts via the platform by appointment.